Susilo, M.E.; Schaller, S.; Jiménez-Franco, L.D.; Kulesza, A.; de Witte, W.E.A.; Chen, S.-C.; Boswell, C.A.; Mandikian, D.; Li, C.-C.
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics 2025, 17, 500.
https://doi.org/10.3390/pharmaceutics17040500
AMA Style
Susilo ME, Schaller S, Jiménez-Franco LD, Kulesza A, de Witte WEA, Chen S-C, Boswell CA, Mandikian D, Li C-C.
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics. 2025; 17(4):500.
https://doi.org/10.3390/pharmaceutics17040500
Chicago/Turabian Style
Susilo, Monica E., Stephan Schaller, Luis David Jiménez-Franco, Alexander Kulesza, Wilhelmus E. A. de Witte, Shang-Chiung Chen, C. Andrew Boswell, Danielle Mandikian, and Chi-Chung Li.
2025. "Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies" Pharmaceutics 17, no. 4: 500.
https://doi.org/10.3390/pharmaceutics17040500
APA Style
Susilo, M. E., Schaller, S., Jiménez-Franco, L. D., Kulesza, A., de Witte, W. E. A., Chen, S.-C., Boswell, C. A., Mandikian, D., & Li, C.-C.
(2025). Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics, 17(4), 500.
https://doi.org/10.3390/pharmaceutics17040500
